Trial Profile
Therapeutic Targets in African-American Youth With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Aug 2023
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Apr 2023 Status changed from recruiting to completed.
- 12 Jan 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.
- 12 Jan 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.